cgp 28392 has been researched along with calcimycin in 1 studies
| Studies (cgp 28392) | Trials (cgp 28392) | Recent Studies (post-2010) (cgp 28392) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 76 | 1 | 2 | 11,946 | 40 | 444 |
| Protein | Taxonomy | cgp 28392 (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisserbe, JC; Eskay, RL; Patel, J | 1 |
1 other study(ies) available for cgp 28392 and calcimycin
| Article | Year |
|---|---|
Evidence that the peripheral-type benzodiazepine receptor ligand Ro 5-4864 inhibits beta-endorphin release from AtT-20 cells by blockade of voltage-dependent calcium channels.
Topics: Animals; Benzodiazepinones; beta-Endorphin; Binding Sites; Calcimycin; Calcium; Cell Differentiation; Cell Division; Cell Line; Colforsin; Corticotropin-Releasing Hormone; Endorphins; Ion Channels; Mice; Pyridines; Receptors, GABA-A | 1986 |